CD133 Marks a Stem Cell Population That Drives Human Primary Myelofibrosis

Haematologica - Italy
doi 10.3324/haematol.2014.118463
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

CD133 Marks a Myogenically Primitive Subpopulation in Rhabdomyosarcoma Cell Lines That Are Relatively Chemoresistant but Sensitive to Mutant HSV

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2012English

Cytokine Expression Pattern in Bone Marrow Microenvironment After Allogeneic Stem Cell Transplantation in Primary Myelofibrosis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Addition of IL-3 to Stem Cell Factor Dependent Primary Human Mast Cell Cultures Induces a Transient Basophilic Cell Population

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Allogeneic Stem Cell Transplantation as Treatment for Myelofibrosis

Bone Marrow Transplantation
TransplantationHematology
2006English

CD133 in Breast Cancer Cells: More Than a Stem Cell Marker

Journal of Oncology
Oncology
2019English

Percoll Gradient Optimization for Blood CD133+ Stem Cell Recovery

Stem Cell Discovery
2014English

Identification of a Distinct Population of CD133+CXCR4+ Cancer Stem Cells in Ovarian Cancer

Scientific Reports
Multidisciplinary
2015English

Incidence and Outcomes of Primary Engraftment Failure in Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Cancer Stem Cell Plasticity Drives Therapeutic Resistance

Cancers
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy